Literature DB >> 29265596

Effects of low-dose melamine exposure during pregnancy on maternal and fetal kidneys in rats.

Ching Yan Chu1, Kwok Pui Fung2, Chi Chiu Wang1,2,3.   

Abstract

Despite the previous reports on melamine contamination in high concentrations some years ago, there were not many studies on low-level exposure in daily life, particularly in pregnancy. We investigated the effect of low-dose melamine on the kidneys of the pregnant rats and their developing embryos/fetuses during various gestational stages namely implantation, gastrulation, organogenesis, maturation and whole pregnancy. Our results showed that the repeated low level of melamine (12.5, 25, and 50 mg/kg bw/d) during pregnancy did not cause obstruction of renal tubules although more precipitating crystals were found in the early gestational periods. Simple hyperplasia in the maternal tubules and pelvic epithelium were more prominent after exposed to melamine during the whole gestational period. Neonatal kidneys significantly suffered more from congestion in glomeruli and interstitium, dilated tubules and interstitial edema after melamine administration to the mother in the late and the whole gestational periods. A trend of advance of glomerular development in fetuses was also observed. We conclude that in utero exposure of low-level melamine could post a risk on the kidneys of the pregnant mother as well as the developing fetuses, which may further increase the possibility of other health problems later in life.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  development; kidney; maternal; melamine; nephrotoxicity; prenatal

Mesh:

Substances:

Year:  2017        PMID: 29265596     DOI: 10.1002/tox.22525

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  1 in total

1.  Inter-day and inter-individual variability in urinary concentrations of melamine and cyanuric acid.

Authors:  Hongkai Zhu; Kurunthachalam Kannan
Journal:  Environ Int       Date:  2018-12-17       Impact factor: 9.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.